HIV & AIDS

Maraviroc-containing HIV PrEP regimens safe, well tolerated

(HealthDay)—Maraviroc (MVC)-containing HIV pre-exposure prophylaxis (PrEP) regimens are well tolerated for preventing HIV infection in uninfected women, according to a study published online Aug. 22 in the Annals of Internal ...

Health

Research on risky sexual behaviors is lacking

Sexual health research focused on men who have sex with men is lacking, according to health researchers, even in the midst of rising rates of sexually transmitted infections, including HIV, in this population.

Oncology & Cancer

Cervical vaccine also protects against anal cancer risk

A vaccine routinely used to shield against cervical cancer caused by the human papillomavirus also reduces women's risk of anal cancer, a study published by the journal The Lancet Oncology on Tuesday says.